Decentralized Clinical Trials: Future of Rare Disease R&D

Discover how decentralized clinical trials (DCTs) are revolutionizing research for rare diseases at the Paris 2025 Congress. Learn about remote monitoring, wearable tech, and patient-centric platforms enabling participation across borders. Hear from CROs, pharma leaders, and regulators working to improve access and data collection for hard-to-reach populations. Explore case studies using hybrid models and virtual tools that streamline rare disease trial logistics. Stay ahead with actionable strategies to implement DCTs ethically, effectively, and inclusively in global rare disease research.

    Related Conference of Decentralized Clinical Trials: Future of Rare Disease R&D

    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    June 08-09, 2026

    20th World Drug Delivery Summit

    London, UK
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    July 27-28, 2026

    19th World Drug Delivery Summit

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland

    Decentralized Clinical Trials: Future of Rare Disease R&D Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in